LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis
Authors
Keywords
-
Journal
Cancer Management and Research
Volume Volume 13, Issue -, Pages 7543-7557
Publisher
Informa UK Limited
Online
2021-10-01
DOI
10.2147/cmar.s329846
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway
- (2020) Xi Wang et al. Frontiers in Oncology
- Long Non-Coding RNA HCG11 Aggravates Osteosarcoma Carcinogenesis via Regulating the microRNA-579/MMP13 Axis
- (2020) Lili Wang et al. International Journal of General Medicine
- Potential new biomarkers for endometrial cancer
- (2019) Michelle H. Townsend et al. Cancer Cell International
- Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
- (2019) Xiaoxu Huang et al. Molecular Cancer
- Genetic Associations With Diabetic Retinopathy and Coronary Artery Disease in Emirati Patients With Type-2 Diabetes Mellitus
- (2019) Sarah K. Azzam et al. Frontiers in Endocrinology
- Burden of Gastric Cancer
- (2019) Aaron P. Thrift et al. Clinical Gastroenterology and Hepatology
- Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial
- (2019) Yasuhide Yamada et al. Lancet Gastroenterology & Hepatology
- Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway
- (2019) Ying Liu et al. ANTI-CANCER DRUGS
- PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis
- (2019) Yinmou Guo et al. BIOMEDICINE & PHARMACOTHERAPY
- Silencing of lncRNA ZFAS1 inhibits malignancies by blocking Wnt/β-catenin signaling in gastric cancer cells
- (2018) Weiran Xu et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer
- (2018) Hao Yuan et al. CANCER LETTERS
- Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a
- (2018) Chuanyao Cheng et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma
- (2018) Shao Jie Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway
- (2018) Yalan Lu et al. CANCER BIOLOGY & THERAPY
- Circular RNA EIF6 (Hsa_circ_0060060) sponges miR-144-3p to promote the cisplatin-resistance of human thyroid carcinoma cells by autophagy regulation
- (2018) Feng Liu et al. Aging-US
- LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194
- (2017) Jihong An et al. OncoTargets and Therapy
- LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis
- (2016) Ben Yue et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- LncRNA HOTAIR promotes cisplatin resistance in gastric cancer by targeting miR-126 to activate the PI3K/AKT/MRP1 genes
- (2016) Jin Yan et al. TUMOR BIOLOGY
- Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9
- (2016) Jing Wang et al. Oncotarget
- Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression
- (2015) Qun Hang et al. ANTI-CANCER DRUGS
- Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance
- (2015) Xian-wen Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB
- (2015) Yiping Du et al. TUMOR BIOLOGY
- Multidrug Resistance-Associated Protein (MRP1, 2, 4 and 5) Expression in Human Corneal Cell Culture Models and Animal Corneal Tissue
- (2014) Jessica Verstraelen et al. MOLECULAR PHARMACEUTICS
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search